TABLE 5.

Results of in vitro antifungal screening, in the form of zones of inhibition (ZOIs; mm), and minimum inhibitory concentration testing on fungal isolates.

S/N	Sample code	C. albicans		A. niger		A. flavus		R. nigricans
		ZOI (mm)	MIC (μg/mL)	ZOI (mm)	MIC (μg/mL)	ZOI (mm)	MIC (μg/mL)	ZOI (mm)	MIC (μg/mL)
1	3a	30.00 ± 0.90	62.50	40.00 ± 1.18	15.62	30.00 ± 0.90	31.25	40.00 ± 1.18	15.62
2	3b	30.00 ± 0.91	7.81	30.00 ± 0.90	7.81	30.00 ± 0.90	15.62	35.00 ± 1.11	7.81
3	3c	30.00 ± 0.90	7.81	35.00 ± 1.11	15.62	30.00 ± 0.91	31.25	35.00 ± 1.10	15.62
4	3d	38.00 ± 1.12	7.81	42.00 ± 1.20	15.62	40.00 ± 0.90	31.25	40.00 ± 1.18	7.81
5	3e	30.00 ± 0.90	31.25	40.00 ± 1.18	15.62	30.00 ± 0.90	62.50	40.00 ± 1.18	15.62
6	3f	35.00 ± 1.12	3.90	40.00 ± 1.18	7.81	40.00 ± 1.20	15.62	40.00 ± 1.18	15.62
7	3g	40.00 ± 1.18	3.90	10.00 ± 0.40	15.62	30.00 ± 0.90	15.62	30.00 ± 0.90	31.25
8	3h	35.00 ± 1.10	7.81	45.00 ± 1.22	15.62	30.00 ± 0.92	31.25	25.00 ± 0.68	62.50
9	3i	35.00 ± 1.10	7.81	35.00 ± 1.11	15.62	40.00 ± 1.20	7.81	35.00 ± 1.10	15.62
10	3j	25.00 ± 0.67	15.62	30.00 ± 0.90	7.81	35.00 ± 1.11	15.62	40.00 ± 1.19	7.81
11	3k	32.00 ± 0.90	31.25	45.00 ± 1.12	31.25	42.00 ± 1.12	7.81	28.00 ± 0.88	15.62
12	3L	30.00 ± 0.90	7.81	40.00 ± 1.18	7.81	35.00 ± 1.10	15.62	40.00 ± 1.18	7.81
13	3m	57.00 ± 1.35	3.90	40.00 ± 1.19	3.90	35.00 ± 1.12	7.81	40.00 ± 1.20	3.90
14	KCZ	57.00 ± 1.36	3.13	40.00 ± 1.18	3.13	47.00 ± 1.28	6.25	25.00 ± 0.68	6.25

Mean ± SD, standard deviation of triplicate measurements. C. albicans = Candida albicans (ATCC, 10231); A. niger = Aspergillus niger (LIO); A. flavus = Aspergillus flavus (LIO); R. nigricans = Rhizopus nigricans (LIO, but sequenced); ATCC, american type culture collection; LIO, locally isolated organism; KCZ, ketoconazole; ZOI, zone of inhibition; MIC, minimum inhibitory concentration.